STOCK TITAN

TuHURA Biosciences sets 5M-share inducement plan

TuHURA Biosciences created a 2026 inducement equity plan with 5,000,000 shares reserved for new-hire awards under Nasdaq rules.

(High)
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

TuHURA Biosciences, Inc. (HURA) adopted the TuHURA Biosciences, Inc. 2026 Inducement Equity Incentive Plan on September 10, 2026, allowing equity awards to new employees as a material inducement to employment under Nasdaq Listing Rule 5635(c)(4). The Board reserved 5,000,000 shares of common stock for issuance under this plan.

The plan, administered by the Board’s Compensation Committee or a majority of independent directors, permits nonqualified stock options, stock appreciation rights, stock, restricted stock, restricted stock units, performance shares, performance units and other stock-based awards, but does not permit incentive stock options. TuHURA also approved a related form of stock option agreement to be used with this inducement plan.

Positive

  • None.

Negative

  • None.

Filing Explained

The 5,000,000-share reserve is authorization for possible future awards, not evidence that shares have been issued; if awards ultimately result in additional shares, existing holders’ percentage ownership would decline absent offsetting changes.

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Inducement Plan share reserve 5,000,000 shares Shares of common stock reserved for issuance under the 2026 Inducement Equity Incentive Plan
Common stock par value $0.001 per share Par value of TuHURA Biosciences’ common stock eligible under the plan
Adoption date of Inducement Plan September 10, 2026 Date the Board adopted the 2026 Inducement Equity Incentive Plan
Trading symbol HURA TuHURA Biosciences common stock listed on The Nasdaq Capital Market
Inducement Equity Incentive Plan financial
"adopted the TuHURA Biosciences, Inc. 2026 Inducement Equity Incentive Plan"
An inducement equity incentive plan is a program that grants employees or executives company shares or stock options to motivate and reward their work, often as a way to attract new talent. It aligns their interests with the company's success, encouraging them to contribute to long-term growth. For investors, such plans can influence a company's stock performance and overall financial health by motivating key personnel.
Nasdaq Listing Rule 5635(c)(4) regulatory
"adopted without stockholder approval pursuant to Nasdaq Listing Rule 5635(c)(4)"
NASDAQ Listing Rule 5635(c)(4) is a rule that requires a company to get approval from its shareholders before selling a large amount of its shares, usually over 20%. This helps protect investors by making sure the company doesn't flood the market with new shares without their say, which could lower the stock's value.
stock appreciation rights financial
"Awards under the Inducement Plan may consist of nonqualified stock options, stock appreciation rights"
Stock appreciation rights (SARs) are a form of employee compensation that give the holder the right to receive the increase in a company's stock price over a set baseline, paid in cash or shares, without having to buy the stock. For investors, SARs matter because they can create future cash outflows or share dilution and signal how a company rewards and motivates executives — similar to giving a bonus tied directly to how well the company’s stock performs.
restricted stock units financial
"may consist of ... restricted stock, restricted stock units, performance shares"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
nonqualified stock options financial
"Awards under the Inducement Plan may consist of nonqualified stock options"
A nonqualified stock option is a company-issued right that lets an employee or contractor buy shares later at a preset price, like a coupon to purchase stock regardless of the market price. It matters to investors because when the option is used the recipient owes ordinary-income tax on the difference between market and preset price, which affects the holder’s financial decisions and can change the company’s share count and reported expenses.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did TuHURA Biosciences (HURA) announce regarding a new equity plan?

TuHURA Biosciences announced adoption of the 2026 Inducement Equity Incentive Plan, allowing equity awards to new employees as a material inducement to employment, consistent with Nasdaq Listing Rule 5635(c)(4), and to be administered by the Board’s Compensation Committee or a majority of independent directors.

How many shares are reserved under TuHURA Biosciences' 2026 Inducement Equity Incentive Plan?

The Board reserved 5,000,000 shares of TuHURA Biosciences’ common stock, par value $0.001 per share, for issuance under the 2026 Inducement Equity Incentive Plan, specifically for equity awards to qualifying new employees.

Who is eligible to receive awards under TuHURA Biosciences (HURA) inducement plan?

Only individuals who satisfy the inducement grant standard under Nasdaq Listing Rule 5635(c)(4) are eligible for awards under the 2026 Inducement Equity Incentive Plan. These grants must be a material inducement to entering into employment with TuHURA Biosciences or its subsidiaries.

What types of awards can TuHURA Biosciences grant under the 2026 Inducement Plan?

Under the 2026 Inducement Plan, TuHURA Biosciences may grant nonqualified stock options, stock appreciation rights, stock, restricted stock, restricted stock units, performance shares, performance units and other stock-based awards; no incentive stock options may be granted under this plan.

Did shareholders approve the TuHURA Biosciences 2026 Inducement Equity Incentive Plan?

The 2026 Inducement Equity Incentive Plan was adopted without stockholder approval, pursuant to Nasdaq Listing Rule 5635(c)(4), which permits inducement grants to new employees under specified conditions.

When did TuHURA Biosciences (HURA) adopt the 2026 Inducement Equity Incentive Plan?

TuHURA Biosciences’ Board of Directors adopted the 2026 Inducement Equity Incentive Plan on September 10, 2026, with the details later reported and accompanied by the full plan and a form of stock option agreement as exhibits.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
0001498382falseTuHURA Biosciences, Inc./NV00014983822026-09-102026-09-10

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): September 10, 2026

TUHURA BIOSCIENCES, INC.

(Exact name of Registrant as Specified in Its Charter)

 

Nevada

001-37823

99-0360497

(State or Other Jurisdiction
of Incorporation)

(Commission File Number)

(IRS Employer
Identification No.)

10500 University Center Dr., Suite 110

Tampa, Florida 33612

(Address of Principal Executive Offices, including zip code)

Registrant’s Telephone Number, Including Area Code: (813) 875-6600

 

N/A

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


 


Title of each class

Trading
Symbol(s)


Name of each exchange on which registered

Common Stock, $0.001 par value per share

 

 

HURA

The Nasdaq Capital Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 


 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

Adoption of the TuHURA Biosciences, Inc. 2026 Inducement Equity Incentive Plan

 

On September 10, 2026, the Board of Directors (the “Board”) of TuHURA Biosciences, Inc. (the “Company”) adopted the TuHURA Biosciences, Inc. 2026 Inducement Equity Incentive Plan (the “Inducement Plan”), pursuant to which the Company may from time to time grant equity awards to new employees as a material inducement to their entering into employment with the Company or one of its subsidiaries. The Inducement Plan was adopted without stockholder approval pursuant to Nasdaq Listing Rule 5635(c)(4) (the “Nasdaq Rule”) and will be administered by the Compensation Committee of the Board (the “Compensation Committee”).

 

The Board reserved 5,000,000 shares of the Company’s common stock, par value $0.001 per share, for issuance under the Inducement Plan. The only persons eligible to receive awards under the Inducement Plan are individuals who satisfy the standard for inducement grants under the Nasdaq Rule. Awards under the Inducement Plan may consist of nonqualified stock options, stock appreciation rights, stock, restricted stock, restricted stock units, performance shares, performance units and other stock-based awards; no incentive stock options may be granted under the Inducement Plan. In accordance with the Nasdaq Rule, awards under the Inducement Plan may be granted only by (i) the Compensation Committee, provided that it is comprised solely of independent directors, or (ii) a majority of the Company’s independent directors. The Board also approved a form of stock option agreement for use under the Inducement Plan (the “Form Inducement Stock Option Agreement”).

 

The foregoing descriptions of the Inducement Plan and the Form Inducement Stock Option Agreement do not purport to be complete and are qualified in their entirety by reference to the full text of the Inducement Plan and the Form Inducement Stock Option Agreement, copies of which are filed as Exhibits 10.1 and 10.2, respectively, to this Current Report on Form 8-K and incorporated herein by reference.

 

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

 

Exhibit No. Description

 

10.1 TuHURA Biosciences, Inc. 2026 Inducement Equity Incentive Plan

10.2 Form Inducement Stock Option Agreement under the TuHURA Biosciences, Inc. 2026 Inducement Equity Incentive Plan

104 Cover Page Interactive Data File (embedded within the inline XBRL document)

 

 

 


 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

TUHURA BIOSCIENCES, INC.

Date:

September 16, 2026

By:

/s/ Dan Dearborn

Name: Dan Dearborn
Title: Chief Financial Officer

 


Filing Exhibits & Attachments

3 documents

Keep reading